Elicio Therapeutics (ELTX) Misses Q3 EPS by 60c
Tweet
Share
E-mailGet Alerts ELTX Hot Sheet
Join SI Premium – FREE
Elicio Therapeutics (NASDAQ: ELTX) reported Q3 EPS of ($0.60).
For earnings history and earnings-related data on Elicio Therapeutics (ELTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
- Situational Awareness is active in options market - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
